Abaxis Inc

Most Recent

  • uploads///veterinarian _
    Healthcare

    Zoetis and Abaxis Announce Antitrust Clearance for Merger

    On July 6, Zoetis (ZTS) and Abaxis (ABAX) announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.

    By Mike Benson
  • uploads///ABAX
    Company & Industry Overviews

    Exploring Abaxis’s Financial Performance

    In fiscal 3Q18, the total revenues generated by Abaxis (ABAX) were $59.6 million compared to $52.7 million in fiscal 3Q17.

    By Kenneth Smith
  • uploads///ABAX
    Company & Industry Overviews

    A Look at the Performances of Abaxis’s Product Categories

    Abaxis (ABAX) markets its products under three categories: instruments, consumables, and other products.

    By Kenneth Smith
  • uploads///ABAX
    Company & Industry Overviews

    An Insight into Abaxis’s Business Segments

    In the medical market, Abaxis (ABAX) targets physicians’ offices across multiple specialties.

    By Kenneth Smith
  • uploads///dog _
    Company & Industry Overviews

    Analysts’ Ratings for Abaxis and Its Peers in February 2018

    Of the ten analysts covering Abaxis in February 2018, two gave the stock “strong buys,” six gave it “holds,” and two gave it “sells.”

    By Kenneth Smith
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.